
The Green Power of Catalysis
With more than 80% of all chemical products manufactured using catalytic processes, catalysts are the number one value generator in the chemical industry.
With more than 80% of all chemical products manufactured using catalytic processes, catalysts are the number one value generator in the chemical industry.
The concept of a circular economy, where materials are recycled and reused, is becoming increasingly important in consumer packaging, driven by regulatory requirements and customer interest. Modern technical advancements make it easier to think of today's goods and products as the resources of tomorrow. One such product is plastic.
When developing an inhaled powder formulation, the drug particles’ properties are critical to successful delivery to the deep lung. The aerodynamic diameter is the key parameter, as it represents how well the particle flies in an air stream.
When manufacturing specialty edible fats, ensuring that the product has the desired properties – such as a stable shelf life, optimal melting behavior, and texture – is essential.
Many life science companies generate large swathes of data.
The demand for medicines is increasing rapidly and R&D pipelines have doubled over the last decade.
Johnson Matthey (JM) looks back at a legacy of 200+ years. Established in 1817, the London, England-based chemical company reported annual revenues of about €18 billion in 2022. JM has built a global presence with operations in more than 30 countries. The company’s strategy is based on the vision for a cleaner, healthier world and mirrors society’s need to create a more sustainable future. JM has set out to catalyze the net zero transition by delivering sustainable solutions to customers enabled by innovative technology and leading positions in JM’s key markets automotive, chemicals, and energy. To get a better understanding of the role JM’s technological developments play for a sustainable future, Michael Reubold spoke with Maurits van Tol, the company’s Chief Technology Officer.
In 2022, the European Commission revised the definition of nanomaterials in a new recommendation, which supports a uniform EU regulatory framework and aims at aligning the legislation across various sectors. Therefore, particle product design is an enabling technology relevant for many sectors, such as chemicals, consumer products, foods and beverages, health, energy, and the environment.
Having survived the pandemic so far in good condition, chemical distributors are well positioned to grow, provided they understand how the rules for winning have changed. Distributors that keep their customers’ needs front and center will be best positioned to succeed, regardless of what the future brings.
Interview with Marc Doyle, CEO of Arxada, which was created following the carve-out and sale of Lonza Specialty Ingredients to private equity firms Bain Capital and Cinven.
Interview with Karl Rotthier, CEO of the Sanofi spin-off EuroAPI.
There is a new urgency in the market for manufacturers and testing organizations to be prepared for rapid, unexpected changes in material resource access, exacerbated by turbulent regional and global events. This focus is in addition to reinforcing routine risk mitigation activities around the raw material supply chain, adding to the relevance and impact of the topic.
Dorothee Arns, Director General of FECC, discusses current challenges, market trends and her vision for the chemical distribution industry in Europe. The interview was conducted by Michael Reubold and Ralf Kempf.
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
Interview with Giovanna Libralon, Senior Director Commercial Development Small Molecules at Lonza.
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
Mergers & acquisitions activity in the chemical distribution industry was high in 2021, but current macro-economic conditions may have a dampening effect on the number of deals that will conclude by the end of this year.
The International Society for Pharmaceutical Engineering (ISPE) announced the 2022 Facility of the Year Awards (FOYA) Category Winners – including an Honorable Mention for Iovance Biotherapeutics, to be the first company in the world to commercially produce a personalized therapy for solid tumors.
It sometimes seems that everyone running a business always thinks that times are tougher now than they used to be. For producers — and buyers — of commodity chemicals, this thinking will take the more specific form of concerns about increased price volatility.
Since the middle of the 1980s, the supply chain of many chemicals has moved east. This was primarily driven by cheaper production costs in China or India, due to lower raw material prices, a cheaper asset base compared to plants in the West, and lower environmental and regulatory standards.
From its inception in 1881, SCI's principal objective has been to further the application of chemistry and related sciences into industry for the public benefit.
The global market for oligonucleotide therapeutics is expanding rapidly. Bachem, an innovation-driven company based in Bubendorf, Switzerland, has entered this competitive environment a few years ago and meanwhile has passed certain milestones on its way to become a preferred oligonucleotide manufacturing partner for pharmaceutical companies.
Chinese small and medium-sized enterprises (SMEs) in the chemical industry and other industries have achieved rapid growth in the past years and are contributing to China’s economic development.
Biovox was founded in 2020 to enable more sustainability through renewable bioplastics even in difficult applications such as consumables in healthcare or machine parts.
China’s 14th Five-Year Plan “145” suggests that the dynamics initiated by the previous Five-Year Plan are to be maintained and even surpassed. As in the previous planning period, high priority is given to modernizing the country and the economy through R&D.